Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Windows to the Previous: An Excursion Through the World's Notable Engineering - 2I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- 3Survey: Canteen Cups With Great Warm Protection Impact
- 4New materials, old physics – the science behind how your winter jacket keeps you warm
- 5Delta flight bound for Atlanta makes emergency landing after engine issue
- Black Friday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
- Hitler's madcap mega-railway would have linked Berlin with India
- Remote Work Survival manual: Helping Efficiency at Home
- Scientists Just Discovered Japan’s First New Bird Species in Over 40 Years
- 2025 Yachting Editors' Choice Awards: Yachts
- 3 Must-Change Settings for iPhone Clients: Safeguard Yourself !
- Partner of crime boss Steven Lyons arrested in Dubai
- The Best Music Collections of the 10 years
- Lucrative Positions in the Advancing Position Market of 2024
